Aflibercept Rescue of Bevacizumab- or Ranibizumab-Resistant Choroidal Neovascularization in Age-Related Macular Degeneration

被引：0
|
作者：
Arcinue, Cheryl [1 ]
Ma, Feiyan [1 ]
Barteselli, Giulio [1 ]
Lee, Su-Na [1 ]
El-Emam, Sharif [1 ]
Doede, Aubrey [1 ]
Gomez, Maria Laura [1 ]
Freeman, William [1 ]
机构：
[1] UCSD Shiley Eye Ctr, Jacobs Retina Ctr, La Jolla, CA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2013年 / 54卷 / 15期
关键词：
453 choroid: neovascularization; 412 age-related macular degeneration; 748 vascular endothelial growth factor;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
4176
引用
收藏
页数：3
相关论文
共 50 条
  • [31] The efficacy of aflibercept in the treatment of neovascular age-related macular degeneration previously treated with bevacizumab or ranibizumab
    Hall, Laura
    Zebardast, Nazlee
    Adelman, Ron
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [32] COST UTILITY ANALYSIS OF AFLIBERCEPT, RANIBIZUMAB, AND BEVACIZUMAB FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Lin, C. W.
    Hay, J.
    VALUE IN HEALTH, 2014, 17 (03) : A287 - A287
  • [33] Cost Comparison of Intravitreal Aflibercept With Bevacizumab and Ranibizumab for the Treatment of Wet Age-Related Macular Degeneration
    Shaikh, Adeel H.
    Toussaint, Brian W.
    Miller, Daniel M.
    Petersen, Michael R.
    Foster, Robert E.
    Riemann, Christopher D.
    Hutchins, Robert K.
    Sisk, Robert A.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2015, 46 (01): : 62 - 66
  • [34] A comparison of responses to intravitreal bevacizumab, ranibizumab, or aflibercept injections for neovascular age-related macular degeneration
    Park, Dae Hyun
    Sun, Hae Jung
    Lee, Sung Jin
    INTERNATIONAL OPHTHALMOLOGY, 2017, 37 (05) : 1205 - 1214
  • [35] Switching from ranibizumab and aflibercept to bevacizumab therapy in neovascular age-related macular degeneration patients
    Calugaru, Dan
    Calugaru, Mihai
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2020, 30 (05) : NP1 - NP2
  • [36] Effects of Intravitreal Aflibercept on Neovascular Age-Related Macular Degeneration Resistant to Intravitreal Ranibizumab
    Suzuki, Katsuya
    Yasukawa, Tsutomu
    Kato, Aki
    Fujino, Shinpei
    Morita, Hiroshi
    Ota, Satoshi
    Hirahara, Shuichiro
    Munenori, Yoshida
    Ogura, Yuichiro
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [37] INTRAVITREAL AFLIBERCEPT IN EYES WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION RESISTANT TO INTRAVITREAL RANIBIZUMAB
    Narayan, Daniel
    Muecke, James
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 42 : 119 - 119
  • [38] Bevacizumab treatment for choroidal neovascularization due to age-related macular degeneration in Japanese patients
    Suzuki, Mihoko
    Gomi, Fumi
    Sawa, Miki
    Tsujikawa, Motokazu
    Sakaguchi, Hirokazu
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2010, 54 (02) : 124 - 128
  • [39] Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration
    Goff, Mitchell J.
    Johnson, Robert N.
    McDonald, H. Richard
    Ai, Everett
    Jumper, J. Michael
    Fu, Arthur
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2007, 27 (04): : 432 - 438
  • [40] Bevacizumab treatment for choroidal neovascularization due to age-related macular degeneration in Japanese patients
    Mihoko Suzuki
    Fumi Gomi
    Miki Sawa
    Motokazu Tsujikawa
    Hirokazu Sakaguchi
    Japanese Journal of Ophthalmology, 2010, 54 : 124 - 128
12345